Park Place Capital’s ResMed RMD Stock Holding History

Park Place Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.2K	Hold	130	–	–	0.01%	435
2025 Q4	$31.3K	Hold	130	–	–	0.01%	399
2025 Q3	$35.6K	Hold	130	–	–	0.01%	377
2025 Q2	$33.3K	Sell	130 -300	-70%	-$71.6K	0.01%	399
2025 Q1	$96.3K	Hold	430	–	–	0.03%	264
2024 Q4	$98.3K	Sell	430 -26	-6%	-$6.26K	0.03%	271
2024 Q3	$111K	Hold	456	–	–	0.03%	274
2024 Q2	$87.3K	Sell	456 -13	-3%	-$2.64K	0.03%	295
2024 Q1	$92.9K	Buy	469 +16	+4%	+$2.93K	0.03%	319
2023 Q4	$77.9K	Buy	453 +13	+3%	+$2K	0.03%	352
2023 Q3	$65.1K	Hold	440	–	–	0.02%	429
2023 Q2	$96.1K	Sell	440 -21	-5%	-$4.68K	0.03%	361
2023 Q1	$101K	Hold	461	–	–	0.03%	350
2022 Q4	$96K	Buy	+461	New	+$101K	0.03%	363

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park Place Capital's RMD Position: Q1 2026 in Review

Park Place Capital held its ResMed (RMD) position steady in Q1 2026 at 130 shares worth $29.2K. The position accounts for 0.01% of the portfolio, ranked #435.

Park Place Capital first reported a position in RMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $111K in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Park Place Capital held 130 shares of ResMed worth $29.2K as of Q1 2026.
Park Place Capital left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.01% of Park Place Capital's portfolio in Q1 2026, its #435 holding.
Park Place Capital first reported a position in ResMed in Q4 2022 and has held it in 14 quarters since.
Park Place Capital's ResMed position peaked at $111K in Q3 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.